Similarly, inhibition of CaM-activated phosphatase, CaN, protected brain cells from neurotoxicity, neuroinflammation and improved cognitive function in experimental models of PD and other neurodegenerative diseases. This evidence concerns the gene NUP214 and Parkinson disease.